INTERNATIONAL PATENT: THE CHINESE UNIVERSITY OF HONG KONG FILES APPLICATION FOR "ADRM1/RPN13 SPLICED VARIANT IN THE PROGNOSIS AND TREATMENT OF HEPATOCELLULAR CARCINOMA"

GENEVA, May 4 -- THE CHINESE UNIVERSITY OF HONG KONG (Shatin, New TerritoriesHong Kong 999077) filed a patent application (PCT/CN2024/078552) for "ADRM1/RPN13 SPLICED VARIANT IN THE PROGNOSIS AND TREATMENT OF HEPATOCELLULAR CARCINOMA" on Feb 26, 2024. With publication no. WO/2025/086513, the details related to the patent application was published on May 01, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WONG, Nathalie (Shatin, New TerritoriesHong Kong 999077), XU, Mingjing (Shatin, New TerritoriesHong Kong 999077)

Abstract: Provided is a method of diagnosing and treating liver disease in...